Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. (Q48303085)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

cerebrospinal fluid

0 references

0 references

author name string

Faustman WO

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Bardgett M

2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Faull KF

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Pfefferbaum A

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Csernansky JG

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Biological Psychiatry

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

45

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

68-75

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Limbic/mesolimbic connections and the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

CSF excitatory amino acids and severity of illness in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Glutamate in schizophrenia: clinical and research implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Neurocircuitry targets in ethanol reward and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Chronic Haloperidol Administration Enhances the γ-Aminobutyric Acid Level in the Rat Striatum without Altering the Glutamate Level

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Cerebrospinal fluid amino acid concentrations in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

A functional link between the limbic cortex and ventral striatum: physiology of the subiculum accumbens pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Evidence of glutamatergic deficiency in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900207-8

7 January 2021

Identifiers

10.1016/S0006-3223(98)00207-8

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9894577

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48303085&oldid=1372144200"